Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.56 -0.42 (-4.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) EV to EBIT (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) EV to EBIT came in at 34.24 for Q2 2026, up 38.3% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) EV to EBIT (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to EBIT at Xeris Biopharma Holdings was 25.65; for FY2025, it came in at 47.95.

  • Quarterly EV to EBIT has run from a low of 24.76 in Q1 2026 to a high of 128.12 in Q3 2025 over five years.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 24.76 (Q1 2026), 47.95 (Q4 2025) and 128.12 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.73 Bn 1.30 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.24
Mar 31, 2026 24.76
Dec 31, 2025 47.95
Sep 30, 2025 128.12
API Access

Xeris Biopharma Holdings EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=XERS&period=max&api_key=YOUR_API_KEY